Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Int J Clin Pract ; 2022: 4741141, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36105787

RESUMO

Objective: To investigate the effect of sufentanil for spinal analgesia during cesarean section. Method: Eligible papers were systematically retrieved from PubMed, Embase, Ovid, and ScienceDirect. Two researchers independently extracted primary and secondary endpoints to compute relative risk and mean difference by using the random-effects model or the fixed-effects model, as appropriate. Publication bias was quantified and assessed using funnel plot and Egger's test. Result: A total of 8 publications with 503 pregnant women were included in this study for meta-analysis. Subarachnoid administration of sufentanil did not significantly reduce the onset time of sensory block and motor block. Nonetheless, subarachnoid administration of sufentanil significantly increased the incidence of postoperative skin pruritus (RR = 5.25, 95%CI: 1.90, 14.49, P < 0.001). Conclusion: Subarachnoid administration of sufentanil has no significant difference in the combined effect value of shortening the onset time of sensory block and motor block, prolonging the onset time of local anesthesia and the incidence of some adverse reactions (such as postoperative nausea, vomiting, hypotension, and tremors). However, the incidence of skin pruritus was significantly increased, and the difference was statistically significant. Because of this, the drug still needs to be used with caution in combination with the actual situation in clinical use.


Assuntos
Analgesia , Sufentanil , Cesárea/efeitos adversos , Feminino , Humanos , Dor , Gravidez , Prurido/induzido quimicamente , Ensaios Clínicos Controlados Aleatórios como Assunto , Sufentanil/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA